Skip to content
Femasys Logo
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis

Category: Media

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

FemCerv®: Well-designed technology that can minimize patient discomfort

The Post-Roe Fertility Journey

US biomedical company launches intrauterine device for tubal evaluation

Femasys Targets Male Infertility with Updated Trial Design

← older
newer →
About Femasys
  • Who We Are
  • Leadership
Investor Relations
  • Overview
  • News
  • Event & Presentations
  • Stock Info
  • Financials
  • Governance
  • Resources
Resources
  • Who We Are
  • Leadership
Contact Us
  • Contact Femasys
  • Join Us
Healthcare Professionals
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Patients
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis